Hamid Band

Title: Hamid Band: Innovator in T Cell Antigen Receptor Technology

Introduction

Hamid Band is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of immunology, particularly in the development of T cell antigen receptor technology. His work has implications for cancer treatment and immunotherapy.

Latest Patents

Hamid Band holds a patent for "Human .gamma., .delta.T cell antigen receptor polypeptides and nucleic acid sequences." This invention is directed to purified polypeptides comprising the .gamma. T cell antigen receptor (TCR) polypeptide, the .delta. TCR polypeptide, a .gamma., .delta. TCR complex, or a fragment thereof containing an epitope. The invention also relates to nucleic acid sequences encoding such polypeptides, and subsequences thereof. In specific embodiments, the invention includes nucleic acid sequences comprising variable, diversity, joining, or constant regions of the .delta. TCR gene sequence. Additionally, it relates to monoclonal antibodies specifically reactive with an epitope of the gamma or delta TCR polypeptides. These antibodies can be identified by detecting co-modulation of the CD3 antigen. Furthermore, the invention encompasses compositions comprising substantially purified cells that express both a .gamma., .delta. TCR and the CD4 antigen.

Career Highlights

Throughout his career, Hamid Band has worked with prominent organizations such as T Cell Sciences, Inc. and Dana-Farber Cancer Institute. His experience in these institutions has allowed him to advance his research and contribute to significant developments in the field of immunology.

Collaborations

Hamid Band has collaborated with esteemed colleagues, including Michael B. Brenner and Jonathan G. Seidman. These partnerships have fostered innovation and have been instrumental in the progress of his research endeavors.

Conclusion

Hamid Band's contributions to T cell antigen receptor technology highlight his role as an influential inventor in the field of immunology. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options for patients.